Fenneteau F[Author] - Search Results

Year	Number of Results
2003	1
2007	1
2008	1
2009	2
2010	1
2012	1
2013	1
2021	1
2024	2

1

Dynamical behavior-based approach for the evaluation of treatment efficacy: The case of immuno-oncology.

Zugaj D, Fenneteau F, Tremblay PO, Nekka F. Zugaj D, et al. Among authors: fenneteau f. Chaos. 2024 Jan 1;34(1):013142. doi: 10.1063/5.0170329. Chaos. 2024. PMID: 38277131

2

Dynamical systems analysis as an additional tool to inform treatment outcomes: The case study of a quantitative systems pharmacology model of immuno-oncology.

Balti A, Zugaj D, Fenneteau F, Tremblay PO, Nekka F. Balti A, et al. Among authors: fenneteau f. Chaos. 2021 Feb;31(2):023124. doi: 10.1063/5.0022238. Chaos. 2021. PMID: 33653032

3

Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans.

Leeds JM, Fenneteau F, Gosselin NH, Mouksassi MS, Kassir N, Marier JF, Chen Y, Grosenbach D, Frimm AE, Honeychurch KM, Chinsangaram J, Tyavanagimatt SR, Hruby DE, Jordan R. Leeds JM, et al. Among authors: fenneteau f. Antimicrob Agents Chemother. 2013 Mar;57(3):1136-43. doi: 10.1128/AAC.00959-12. Epub 2012 Dec 17. Antimicrob Agents Chemother. 2013. PMID: 23254433 Free PMC article.

4

Predicting efficacy assessment of combined treatment of radiotherapy and nivolumab for NSCLC patients through virtual clinical trials using QSP modeling.

Schirru M, Charef H, Ismaili KE, Fenneteau F, Zugaj D, Tremblay PO, Nekka F. Schirru M, et al. Among authors: fenneteau f. J Pharmacokinet Pharmacodyn. 2024 Mar 17. doi: 10.1007/s10928-024-09903-0. Online ahead of print. J Pharmacokinet Pharmacodyn. 2024. PMID: 38493439

5

Modeling of scale-down effects on the hydrodynamics of expanded bed adsorption columns.

Fenneteau F, Aomari H, Chahal P, Legros R. Fenneteau F, et al. Biotechnol Bioeng. 2003 Mar 30;81(7):790-9. doi: 10.1002/bit.10522. Biotechnol Bioeng. 2003. PMID: 12557312

6

Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysis.

Fenneteau F, Li J, Nekka F. Fenneteau F, et al. J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):495-522. doi: 10.1007/s10928-009-9134-8. Epub 2009 Oct 22. J Pharmacokinet Pharmacodyn. 2009. PMID: 19847628

7

Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.

Fenneteau F, Poulin P, Nekka F. Fenneteau F, et al. J Pharm Sci. 2010 Jan;99(1):486-514. doi: 10.1002/jps.21802. J Pharm Sci. 2010. PMID: 19479982

8

Assessing pharmacokinetic variability directly induced by drug intake behaviour through development of a feeding behaviour-pharmacokinetic model.

Li J, Petit-Jetté CE, Gohore Bi D, Fenneteau F, Del Castillo JR, Nekka F. Li J, et al. Among authors: fenneteau f. J Theor Biol. 2008 Apr 7;251(3):468-79. doi: 10.1016/j.jtbi.2007.11.033. Epub 2007 Dec 3. J Theor Biol. 2008. PMID: 18234231

9

Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination.

Fenneteau F, Turgeon J, Couture L, Michaud V, Li J, Nekka F. Fenneteau F, et al. Theor Biol Med Model. 2009 Jan 15;6:2. doi: 10.1186/1742-4682-6-2. Theor Biol Med Model. 2009. PMID: 19146691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year